Skip to menu Skip to content Skip to footer
Dr Adam Stewart
Dr

Adam Stewart

Email: 

Overview

Background

Adam G. Stewart, BBiomedSci, MBBS (Hons), MPHTM, FRACP, FRCPA

Dr Adam Stewart is an Infectious Diseases Physician, Clinical Microbiologist and Physician-Scientist.

His research interests include clinical trials, new antimicrobials, diagnostics for infectious diseases, and infections involving transplant recipients and other immunocompromised patients.

Availability

Dr Adam Stewart is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Biomedical Science, Griffith University
  • Bachelor of Medicine and Surgery and Medical Science, Griffith University
  • Masters (Coursework) of Public Health and Tropical Medicine, James Cook University

Research interests

  • New Antimicrobials

    Pre-clinical and clinical research evaluating the efficacy of new antibacterial, antifungal and antiviral agents

  • Clinical Trials in Infectious Diseases

    Randomised controlled trials to identify better treatment options for the management of infectious diseases

  • Diagnostics in Infectious Diseases

    Evaluating the clinical utility of novel diagnostic platforms with regards to predicting risk of infection, pathogen identification and antimicrobial resistance testing

  • Infectious Complications in Transplant Recipients

    Improving surveillance, detection and management of infectious diseases in solid organ and haematopoietic stem cell transplant recipients

Works

Search Professor Adam Stewart’s works on UQ eSpace

72 works between 2015 and 2024

21 - 40 of 72 works

2022

Journal Article

Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections

Laupland, Kevin B., Harris, Patrick N. A., Stewart, Adam G., Edwards, Felicity and Paterson, David L. (2022). Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections. Diagnostic Microbiology and Infectious Disease, 104 (3) 115772, 1-5. doi: 10.1016/j.diagmicrobio.2022.115772

Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections

2022

Journal Article

Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

Madden, Danielle E., McCarthy, Kate L., Bell, Scott C., Olagoke, Olusola, Baird, Timothy, Neill, Jane, Ramsay, Kay A., Kidd, Timothy J., Stewart, Adam G., Subedi, Shradha, Choong, Keat, Fraser, Tamieka A., Sarovich, Derek S. and Price, Erin P. (2022). Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR. Journal of Medical Microbiology, 71 (10) 001593, 1-10. doi: 10.1099/jmm.0.001593

Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

2022

Journal Article

Periurethral abscess etiology, risk factors, treatment options, and outcomes: A systematic review

Tariq, Arsalan, Stewart, Adam G., Desai, Devang J., Britton, Sumudu, Dunglison, Nigel, Esler, Rachel and Roberts, Matthew J. (2022). Periurethral abscess etiology, risk factors, treatment options, and outcomes: A systematic review. Current Urology, Publish Ahead of Print (2), 100-108. doi: 10.1097/cu9.0000000000000159

Periurethral abscess etiology, risk factors, treatment options, and outcomes: A systematic review

2022

Journal Article

An Australian perspective on antimicrobial stewardship programs and transplantation

Stewart, Adam G., Isler, Burcu and Paterson, David L. (2022). An Australian perspective on antimicrobial stewardship programs and transplantation. Transplant Infectious Disease, 24 (5) e13912, 1-4. doi: 10.1111/tid.13912

An Australian perspective on antimicrobial stewardship programs and transplantation

2022

Journal Article

Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates

Isler, Burcu, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Stewart, Adam, Simos, Peter, Falconer, Caitlin, Bauer, Michelle J., Forde, Brian, Harris, Patrick, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe ... Can, Füsun (2022). Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates. Diagnostic Microbiology and Infectious Disease, 104 (1) 115745, 1-4. doi: 10.1016/j.diagmicrobio.2022.115745

Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates

2022

Journal Article

Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality

Laupland, Kevin B., Paterson, David L., Stewart, Adam G., Edwards, Felicity and Harris, Patrick N. A. (2022). Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality. International Journal of Infectious Diseases, 119, 172-177. doi: 10.1016/j.ijid.2022.03.060

Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality

2022

Journal Article

Painless penile periurethral polymicrobial abscess causing urinary retention

Tariq, Arsalan, Stewart, Adam G., Teloken, Patrick E., Dunglison, Nigel T., Martin, Benjamin F. and Roberts, Matthew J. (2022). Painless penile periurethral polymicrobial abscess causing urinary retention. Urology Case Reports, 42 102037, 1-3. doi: 10.1016/j.eucr.2022.102037

Painless penile periurethral polymicrobial abscess causing urinary retention

2022

Journal Article

Reducing the off-target endocrinologic adverse effects of azole antifungals – can it be done?

Balcerek, Matthew I., Stewart, Adam G., Chapman, Paul and Lazarus, Syndia (2022). Reducing the off-target endocrinologic adverse effects of azole antifungals – can it be done?. International Journal of Antimicrobial Agents, 59 (5) 106587, 106587. doi: 10.1016/j.ijantimicag.2022.106587

Reducing the off-target endocrinologic adverse effects of azole antifungals – can it be done?

2022

Journal Article

Morganella morganii, an emerging cause of bloodstream infections

Laupland, Kevin B., Paterson, David L., Edwards, Felicity, Stewart, Adam G. and Harris, Patrick N. A. (2022). Morganella morganii, an emerging cause of bloodstream infections. Microbiology Spectrum, 10 (3), e0056922. doi: 10.1128/spectrum.00569-22

Morganella morganii, an emerging cause of bloodstream infections

2022

Journal Article

Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia

Simos, Peter A., Holland, David J., Stewart, Adam, Isler, Burcu, Hughes, Ian, Price, Nathan, Henderson, Andrew and Alcorn, Kylie (2022). Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy, 77 (7), 2003-2010. doi: 10.1093/jac/dkac129

Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia

2022

Journal Article

Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID ‐19: a systematic review

Christensen, Jacob, O'Callaghan, Kevin, Sinclair, Holly, Hawke, Kate, Love, Amanda, Hajkowicz, Krispin and Stewart, Adam G. (2022). Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID ‐19: a systematic review. Internal Medicine Journal, 52 (4) imj.15432, 522-529. doi: 10.1111/imj.15432

Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID ‐19: a systematic review

2022

Journal Article

Shewanella spp. bloodstream infections in Queensland, Australia

Laupland, Kevin B, Stewart, Adam G, Edwards, Felicity, Paterson, David L, Coulter, Sonali, Heney, Claire, George, Narelle and Harris, Patrick (2022). Shewanella spp. bloodstream infections in Queensland, Australia. Emerging Infectious Diseases, 28 (4), 701-706. doi: 10.3201/eid2804.212193

Shewanella spp. bloodstream infections in Queensland, Australia

2022

Journal Article

Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis

Simos, Peter and Stewart, Adam G. (2022). Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis. Internal Medicine Journal, 52 (2), 332-333. doi: 10.1111/imj.15684

Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis

2022

Journal Article

Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019

Laupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick, Heney, Claire, George, Narelle, Coulter, Sonali and Paterson, David L. (2022). Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019. European Journal of Clinical Microbiology and Infectious Diseases, 41 (4), 609-614. doi: 10.1007/s10096-022-04411-w

Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019

2021

Journal Article

Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial

Stewart, Adam G, Henderson, Andrew, Bauer, Michelle J, Paterson, David L and Harris, Patrick N A (2021). Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial. JAC-Antimicrobial Resistance, 4 (1) dlab192, dlab192. doi: 10.1093/jacamr/dlab192

Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial

2021

Journal Article

Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial

Stewart, Adam G., Harris, Patrick N. A., Chatfield, Mark D., Littleford, Roberta and Paterson, David L. (2021). Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial. Trials, 22 (1) 301, 301. doi: 10.1186/s13063-021-05206-8

Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial

2021

Journal Article

A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review

Henderson, Andrew, Bursle, Evan, Stewart, Adam, Harris, Patrick N. A., Paterson, David, Chatfield, Mark D., Paul, Mical, Dickstein, Yaakov, Rodriguez-Baño, Jesus, Turnidge, John D. and Kahlmeter, Gunnar (2021). A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. Clinical Microbiology and Infection, 27 (12), 1746-1753. doi: 10.1016/j.cmi.2021.03.019

A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review

2021

Journal Article

An update on the laboratory diagnosis of Rickettsia spp. infection

Stewart, Adam G. and Stewart, Alexandra G. A. (2021). An update on the laboratory diagnosis of Rickettsia spp. infection. Pathogens, 10 (10) 1319, 1319. doi: 10.3390/pathogens10101319

An update on the laboratory diagnosis of Rickettsia spp. infection

2021

Journal Article

An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ response

Isler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2021). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ response. Journal of Antimicrobial Chemotherapy, 76 (12), 3327-3328. doi: 10.1093/jac/dkab366

An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ response

2021

Journal Article

Cryptococcus neoformans infection as a cause of severe hyperammonaemia and encephalopathy

Stewart, Adam G., Sinclair, Holly, Chapman, Paul, Baboolal, Keshwar, Barber, Bridget E. and Townsend, Shane (2021). Cryptococcus neoformans infection as a cause of severe hyperammonaemia and encephalopathy. Internal Medicine Journal, 51 (10), 1750-1751. doi: 10.1111/imj.15516

Cryptococcus neoformans infection as a cause of severe hyperammonaemia and encephalopathy

Funding

Current funding

  • 2020 - 2025
    COVID-19 Cure Research (Paterson)
    Royal Brisbane and Women's Hospital Foundation
    Open grant

Past funding

  • 2020 - 2022
    Assessing in vitro activity of oral third generation cephalosporin / beta-lactamase inhibitor combinations against extended spectrum beta-lactamase (ESBL) producing uropathogens
    The Royal College of Pathologists of Australasia
    Open grant
  • 2020 - 2021
    USE OF THERAPEUTIC DRUG MONITORING (TDM) TO OPTIMISE ORAL/ENTERAL HYDROXYCHLOROQUINE DOSING IN CRITICALLY ILL PATIENTS WITH COVID-19 (MRFF CRR Respiratory Medicine administered by QUT)
    Queensland University of Technology
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on gut microbiota of hospitalized patients
    Avant Mutual Group Limited
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on the gut microbiome of hospitalized patients
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3
    Merck Sharp & Dohme Australia
    Open grant
  • 2018 - 2021
    A multicentre, Parallel Group Open-label RC Non-Inferiority Trial of piperacillin-tazobactam versus meropenem for definitive treatment of bloodstream infection due to AmpC-producing Enterobacterales
    Junior Doctor Research Fellowships
    Open grant

Supervision

Availability

Dr Adam Stewart is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

Contact Dr Adam Stewart directly for media enquiries about:

  • clinical trial
  • infectious diseases
  • superbugs

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au